These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1919542)

  • 1. Pharmacological blocking agents for treating substance abuse.
    Kosten TA; Kosten TR
    J Nerv Ment Dis; 1991 Oct; 179(10):583-92. PubMed ID: 1919542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medications for substance use disorders.
    Douaihy AB; Kelly TM; Sullivan C
    Soc Work Public Health; 2013; 28(3-4):264-78. PubMed ID: 23731419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addiction pharmacotherapy 2000: new options, new challenges.
    Rawson RA; McCann MJ; Hasson AJ; Ling W
    J Psychoactive Drugs; 2000; 32(4):371-8. PubMed ID: 11210198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving.
    Heidbreder CA; Hagan JJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):107-18. PubMed ID: 15661634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical uses of naltrexone: a review of the evidence.
    Modesto-Lowe V; Van Kirk J
    Exp Clin Psychopharmacol; 2002 Aug; 10(3):213-27. PubMed ID: 12233982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drugs against alcohol abuse].
    Mørland J
    Tidsskr Nor Laegeforen; 2006 Dec; 126(24):3268-9. PubMed ID: 17170774
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological treatments for substance use disorders.
    Bailey KP
    J Psychosoc Nurs Ment Health Serv; 2004 Aug; 42(8):14-20. PubMed ID: 15354595
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].
    Wobrock T; D'Amelio R; Falkai P
    Nervenarzt; 2008 Jan; 79(1):17-8, 20-2, 24-6 passim. PubMed ID: 17619840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy for Substance Use Disorders.
    Klein JW
    Med Clin North Am; 2016 Jul; 100(4):891-910. PubMed ID: 27235620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of opioid antagonists in treating intravenous cocaine abuse.
    Kosten TR; Kleber HD; Morgan C
    Life Sci; 1989; 44(13):887-92. PubMed ID: 2927249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic approaches to the management of alcoholism.
    Anton RF
    J Clin Psychiatry; 2001; 62 Suppl 20():11-7. PubMed ID: 11584870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement.
    Carroll KM; Ball SA; Nich C; O'Connor PG; Eagan DA; Frankforter TL; Triffleman EG; Shi J; Rounsaville BJ
    Arch Gen Psychiatry; 2001 Aug; 58(8):755-61. PubMed ID: 11483141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological treatment of alcohol dependence: a review of the evidence.
    Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
    JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contingency management: utility in the treatment of drug abuse disorders.
    Stitzer ML; Vandrey R
    Clin Pharmacol Ther; 2008 Apr; 83(4):644-7. PubMed ID: 18305456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication assisted treatment of drug abuse and dependence: global availability and utilization.
    Kresina TF
    Recent Pat Antiinfect Drug Discov; 2007 Jan; 2(1):79-86. PubMed ID: 18221165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram.
    Petrakis IL; Nich C; Ralevski E
    Schizophr Bull; 2006 Oct; 32(4):644-54. PubMed ID: 16887890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone and disulfiram in patients with alcohol dependence and current depression.
    Petrakis I; Ralevski E; Nich C; Levinson C; Carroll K; Poling J; Rounsaville B;
    J Clin Psychopharmacol; 2007 Apr; 27(2):160-5. PubMed ID: 17414239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of opioid antagonists and psychosocial therapy in the treatment of narcotic and alcohol dependence.
    O'Malley SS
    J Clin Psychiatry; 1995; 56 Suppl 7():30-8. PubMed ID: 7673103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurobiological mechanisms and pharmacological treatment options for alcohol craving].
    Hillemacher T; Kornhuber J; Bleich S
    Fortschr Neurol Psychiatr; 2007 Jan; 75(1):26-32. PubMed ID: 17031777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders.
    Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Rounsaville B;
    Biol Psychiatry; 2005 May; 57(10):1128-37. PubMed ID: 15866552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.